PKCδ activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells.
about
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapyThe role of hypoxia-inducible factor-1α in zinc oxide nanoparticle-induced nephrotoxicity in vitro and in vivoRole of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsNADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicityA novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.Protein kinase C, an elusive therapeutic target?Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo.Oxidative stress in angiogenesis and vascular diseaseProstate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species.Protein kinase C-δ (PKCδ) regulates proinflammatory chemokine expression through cytosolic interaction with the NF-κB subunit p65 in vascular smooth muscle cells.Protein kinase C and cancer: what we know and what we do not.The many hats of protein kinase Cδ: one enzyme with many functions.SL4, a chalcone-based compound, induces apoptosis in human cancer cells by activation of the ROS/MAPK signalling pathway.Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) productionCCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.Quantitative proteomic analysis reveals induction of premature senescence in human umbilical vein endothelial cells exposed to chronic low-dose rate gamma radiation.Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics.[Effects of cetuximab combined with celecoxib on apoptosis and KDR and AQP1 expression in lung cancer].Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study.Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.Microvessel density is high in clear-cell renal cell carcinomas of Ukrainian patients exposed to chronic persistent low-dose ionizing radiation after the Chernobyl accident.Protein Kinase C (PKC) Isozymes and Cancer
P2860
Q24597964-80DEE041-8EA7-4741-B196-7A483A83E22DQ28390139-E0616BE2-E719-483E-BBDF-9DA2243E49FDQ36311581-088FF97E-0292-4A5F-97C8-86AD040684A4Q36500327-98E2CD36-6764-4AAF-81CD-C379C6E3A104Q36656128-2326C879-395C-402A-9C90-3D3D977412B4Q36749014-367B25B7-8407-467F-9DBF-842719EBDD9EQ37141320-B41E595B-A645-46ED-9A63-68FE76834370Q37340973-4354F61A-67F4-45B1-86A0-77FF180395E4Q37535220-218092AD-BE66-4B16-AB1B-5FDD6D368BF0Q37536928-90046051-5EF0-4DF9-9F7D-C5D08EA01124Q37691622-24FFC437-1AA8-4A32-934D-D48A7C8EF5A1Q38171231-65ED1EA0-D18C-4B1B-898E-12D81B98B9C6Q38268437-D6DA4BE1-8A10-4935-A839-8246B7FBDE7DQ38825003-CEBD9E78-0D99-4F9D-96FA-920F30752254Q39431398-DCF1BEAC-09BA-4634-A646-5971513CC2CEQ42183259-03D30231-BF5B-4AB4-ADBA-1DDF9A6F6CCBQ45357105-A942C1C3-0A4F-4B92-9A47-7235D356DF23Q45369219-F395EE21-A93F-47F6-9727-8504360065D3Q46337863-64776191-5054-43F6-91C6-4F3489D6BF56Q46345734-72CACF18-E53B-43C6-A42A-CFEDD90779A5Q47131231-DD777518-0E13-4145-80FF-FDFDDD73ADDCQ48443748-763E2988-0FDE-4186-AC74-86081381AC8BQ59072618-87017C26-C6A9-4AC4-B9B4-03EEF2E6A4F9
P2860
PKCδ activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@ast
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@en
type
label
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@ast
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@en
prefLabel
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@ast
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@en
P2860
P356
P1433
P1476
PKCδ activation mediates angio ...... in PC-3 prostate cancer cells.
@en
P2093
Jeewon Kim
Tomoyoshi Koyanagi
P2860
P304
P356
10.1002/PROS.21310
P577
2010-11-23T00:00:00Z